CuRNA, Inc.
USPTO PatentsView assignee record - 101 granted patents across 12 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Curna ranks #3,623 of 49,997 tracked US assignees by granted-patent volume, with 101 patents across 12 technology areas.
- #3,623
- of 49,997 US assignees by volume
- Top 42%
- by Innovation Score (37.8/100)
- 14.1
- avg claims per patent
- -88%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R3623 · US Corporation #3,623 · 101 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MID 101 grants
- TOP-DECILE #3,623/49,997
- PHOTO-FINISH Chang Chun Petrochem…
- CPC-FOCUS A61P · 12 areas
- INNOV-THIN 37.8/100
- CLAIMS-RICH 14.1 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -88% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Chang Chun Petrochemical Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Curna’s 37.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Curna
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Binj Laboratories · near
Binj Laboratories · near
38 score
- CuRNA · this assignee
CuRNA · this assignee
38 score
- Custom Molded Products · near
Custom Molded Products · near
38 score
- ESW Holdings · near
ESW Holdings · near
38 score
- Network-1 · near
Network-1 · near
38 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Curna's Innovation Score is 37.8/100 (top 42% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Curna?
Each dot is one of Curna’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Curna’s own 14.1 claims/patent is ABOVE the 13.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Curna's grants concentrate
CuRNA, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 99% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (27 grants) versus a trough of 1 in 2023. By volume, Curna sits between Chang Chun Petrochemical Co., Ltd. and HM.CLAUSE, Inc..
Curna's three-year grant acceleration
From 2019–2021 to 2022–2024, CuRNA, Inc. moved from 23 to 4 grants (0.17x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #3,125. See the growth leaderboard.
Who files at CuRNA's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Chang Chun Petroc…
Chang Chun Petrochemical Co., Ltd.
101 patents
- Chimei
Chimei Corporation
101 patents
- Consiglio Naziona…
Consiglio Nazionale Delle Ricerche
101 patents
- CPG
CPG Technologies, LLC
101 patents
- Delphi Internatio…
Delphi International Operations Luxembourg S.A.R.L.
101 patents
- FCI Americas Tech…
FCI Americas Technology LLC
101 patents
- Fameccanica Data…
Fameccanica.Data S.p.A.
101 patents
- HM Clause
HM.CLAUSE, Inc.
101 patents
- Curna ◀
CuRNA, Inc.
101 patents
What this shows CuRNA holds 101 patents at rank #3,623, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near CuRNA
By rank, the assignees closest to #3,623 in granted patent volume.
- Chang Chun Petrochemical Co., Ltd. #3,619 · 101 patents
- Chimei Corporation #3,620 · 101 patents
- Consiglio Nazionale Delle Ricerche #3,621 · 101 patents
- CPG Technologies, LLC #3,622 · 101 patents
- Delphi International Operations Luxembourg S.A.R.L. #3,624 · 101 patents
- FCI Americas Technology LLC #3,625 · 101 patents
- Fameccanica.Data S.p.A. #3,626 · 101 patents
- HM.CLAUSE, Inc. #3,627 · 101 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in CuRNA's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for CuRNA, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), CuRNA ranks #154 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (38 here).
Similar claim depth
Nearest assignees by average claims per patent (14.1 here).
Curna's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
38 Top 42% higher than 58% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 27 | 26.7% |
| 2016 | 10 | 9.9% |
| 2017 | 20 | 19.8% |
| 2018 | 17 | 16.8% |
| 2019 | 16 | 15.8% |
| 2020 | 5 | 5.0% |
| 2021 | 2 | 2.0% |
| 2022 | 3 | 3.0% |
| 2023 | 1 | 1.0% |
Which technologies does CuRNA, Inc. patent most?
Top 12 of 12 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
CuRNA, Inc.'s patent record in context - here's where to go next.
- CuRNA, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 99% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #3,623 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare CuRNA, Inc. against Chang Chun Petrochemical Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 37.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.